As mentioned above, the drastic difference between the cancer cell lines carrying mutant p53 proteins versus the wild-type model may be explained by, among other causes, the opposite effects that p53 variants play in the context of cancer cells proliferation and chemoresistance. This evidence concerns the gene TP53 and cancer.